Pregabalin for the discontinuation of long-term benzodiazepines use: An assessment of its effectiveness in daily clinical practice

No abstract is available for this paper.

• Publication year

  2012

• Venue

  European psychiatry

• Publication date

  2012-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.eurpsy.2010.12.004PMID 21334859
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal.

  2009cited by this paper
• Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: a pooled analysis of 6 studies.

  2008cited by this paper
• Pregabalin in the discontinuation of long-term benzodiazepine use: a case-series.

  2008cited by this paper
• Pregabalin in the discontinuation of long‐term benzodiazepines' use

  2008cited by this paper
• Treatment of alcohol withdrawal syndrome with carbamazepine, gabapentin, and nitrous oxide.

  2008cited by this paper
• P.6.a.009 Pregabalin versus naltrexone in alcohol dependence: results from a multicenter, rondomized, double-blind, comparison trial

  2008cited by this paper
• Pregabalin in Benzodiazepine Withdrawal

  2007cited by this paper
• Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.

  2007cited by this paper
• Pregabalin: its efficacy, safety and tolerability profile in generalized anxiety.

  2007cited by this paper
• Strategies for discontinuing long-term benzodiazepine use

  2006cited by this paper
• Pregabalin for the treatment of generalised anxiety disorder

  2006cited by this paper
• Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings.

  2006influential reference
• Pregabalin

  2006influential reference
• A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo.

  2005cited by this paper
• Attitudes toward benzodiazepines over the years.

  2005cited by this paper
• The diagnosis and management of benzodiazepine dependence

  2005cited by this paper
• Benzodiazepine co-dependence exacerbates the opiate withdrawal syndrome.

  2004cited by this paper
• Prescription psychotropic medication use among the U.S. adult population: results from the third National Health and Nutrition Examination Survey, 1988-1994.

  2004cited by this paper
• Add-on gabapentin in the treatment of opiate withdrawal.

  2004cited by this paper
• Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom.

  2002cited by this paper
• Treatment of out-patients with complicated benzodiazepine dependence: comparison of two approaches.

  2002cited by this paper
• Validación de las versiones en español de la Montgomery-Asberg Depression Rating Scale y la Hamilton Anxiety Rating Scale para la evaluación de la depresión y de la ansiedad

  2002cited by this paper
• [Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton anxiety rating scales].

  2002cited by this paper
• The Benzodiazepine Withdrawal Symptom Questionnaire: psychometric evaluation during a discontinuation program in depressed chronic benzodiazepine users in general practice.

  2002cited by this paper
• Gabapentin Use in Benzodiazepine Dependence and Detoxification

  2001cited by this paper
• Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.

  2000influential reference
• Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal symptoms and taper outcome

  1999cited by this paper
• [Validation of the Spanish version of the Liebowitz social anxiety scale, social anxiety and distress scale and Sheehan disability inventory for the evaluation of social phobia].

  1999influential reference
• The measurement of disability

  1996influential reference
• The treatment of benzodiazepine dependence.

  1994cited by this paper
• Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Effects on withdrawal severity and outcome.

  1991cited by this paper
• A Double-Blind Comparison of the Effects of Gradual Withdrawal of Lorazepam, Diazepam and Bromazepam in Benzodiazepine Dependence

  1991cited by this paper
• A Double-Blind Placebo-Controlled Study of Buspirone in Diazepam Withdrawal in Chronic Benzodiazepine Users

  1990cited by this paper
• The Benzodiazepine Withdrawal Symptom Questionnaire.

  1990cited by this paper
• Effect Sizes for Interpreting Changes in Health Status

  1989cited by this paper
• Treatment of benzodiazepine dependence

  1987cited by this paper
• Department of Health, Education, and Welfare

  1974cited by this paper
• EUROPEAN PSYCHIATRY

  1961cited by this paper
• The assessment of anxiety states by rating.

  1959cited by this paper

• Synergistic Effect of Passiflora incarnata L., Herba and Cognitive Behavioural Therapy in the Management of Benzodiazepine Misuse

  2026cites this paper
• Z-drug abuse and dependence: clinical guideline of the Brazilian Academy of Neurology for diagnosis and management

  2025cites this paper
• A prospective cohort of treatment-seeking patients with problematic use of prescription narcotic drugs: study protocol and baseline characteristics

  2024cites this paper
• Passiflora incarnata L., herba, in benzodiazepine tapering: long-term safety and efficacy in a real-world setting

  2024cites this paper
• Add-On Treatment with Passiflora incarnata L., herba, during Benzodiazepine Tapering in Patients with Depression and Anxiety: A Real-World Study

  2023cites this paper
• Non-opioid antinociceptive drugs : risk of respiratory depression and death related to concomitant use of gabapentinoids in addition to opioids

  2023cites this paper
• Revisiting benzodiazepines (GABA Enhancers):A transdiagnostic and precision medicine approach.

  2023cites this paper
• Hypnotic Discontinuation in Chronic Insomnia.

  2022cites this paper
• The use of sedative medications, their prevalence, and their sedation of patients with disorders of consciousness, as well as the stimulating and sedative effects of alcohol

  2022cites this paper
• Pregabalin for the treatment of generalized anxiety disorder

  2022cites this paper
• Benzodiazepines Remain Important Therapeutic Options in Psychiatric Practice

  2022cites this paper
• Clinical management of withdrawal from benzodiazepine anxiolytic and hypnotic medications.

  2021cites this paper
• Metabolic diversity as a reason for unsuccessful detoxification from benzodiazepines: the rationale for serum BZD concentration monitoring

  2021cites this paper
• Pregabalin Abuse - A Case Report.

  2021cites this paper
• Pregabalinmissbrauch und -Abhängigkeit in verschiedenen europäischen Ländern im Hinblick auf deren Substitutionspolitik

  2021cites this paper
• Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders

  2021cites this paper
• Hypnotic Discontinuation in Chronic Insomnia.

  2020cites this paper
• Pharmacological Treatment of Generalized Anxiety Disorder (GAD)

  2020cites this paper
• Approaches to managing benzodiazepines

  2020cites this paper
• Benzodiazepine and Nonbenzodiazepine Hypnotics (Z-Drugs): The Other Epidemic

  2020cites this paper
• Pregabalin as adjunctive therapy in benzodiazepine discontinuation

  2018influential citation
• Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients

  2018cites this paper
• Hypnotic Discontinuation in Chronic Insomnia.

  2018cites this paper
• Review: Adjunctive pharmacologic approaches for benzodiazepine tapers.

  2018cites this paper
• Pregabalin use in HIV-infected patients with opioid dependence syndrome

  2018cites this paper
• Novel Approaches in Assessing Abuse Potential of Psychotropic Medications - Pregabalin as a Test Case

  2016influential citation
• Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review

  2016cites this paper
• S3-Leitlinie Angststörungen

  2015cites this paper
• Pregabalina w terapii zaburzeń lękowych

  2015cites this paper
• Benzodiazepine Abuse and Addiction

  2015cites this paper
• Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users.

  2015cites this paper
• TITLE : Discontinuation Strategies for Patients with Long-term Benzodiazepine Use : A Review of Clinical Evidence and Guidelines

  2015cites this paper
• Pregabalina w terapii zaburzeń lękowych Pregabalin in the treatment of anxiety disorders

  2015cites this paper
• Off-Label Use of Medications for Treatment of Benzodiazepine Use Disorder.

  2015cites this paper
• TITLE: Discontinuation Strategies for Patients with Long-Term Benzodiazepine Use: Clinical Evidence and Guidelines DATE: 23 January 2015 RESEARCH QUESTIONS 1. What is the clinical evidence regarding strategies to safely and effectively discontinue adult patients from long-term benzodiazepine use? 2.

  2015cites this paper
• The problems of long-term treatment with benzodiazepines and related substances.

  2015cites this paper
• Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review

  2015cites this paper
• Anticonvulsant Agents for the Management of Benzodiazepine Dependence

  2014cites this paper
• [The use of pregabalin without prescription].

  2014cites this paper
• Pregabalin serum levels in apprehended drivers.

  2014cites this paper
• [Pregabalin Dependence: A Case Report].

  2014cites this paper
• Pregabalin for detoxification from opioids: a single case study

  2014cites this paper
• The use of pregabalin without prescription

  2014cites this paper
• Применение прегабалина без назначения врача

  2014cites this paper
• Pregabalin abuse among opiate addicted patients

  2013cites this paper
• Modeling Spanish anxiolytic consumption: Economic, demographic and behavioral influences

  2013cites this paper
• Factors associated with pregabalin dispensing at higher than the approved maximum dose

  2013cites this paper
• MODELIZACIÓN MATEMÁTICA DEL EFECTO DE LA ECONOMÍA EN DESORDENES DEL COMPORTAMIENTO: ADICCIONES, COSTES PERSONALES Y SOCIALES

  2013cites this paper
• Pregabalin for the treatment of generalized anxiety disorder: an update

  2013cites this paper
• Efficacy and safety of pregabalin in the treatment of alcohol and benzodiazepine dependence

  2012cites this paper
• [Pregabalin for the reduction of opiate withdrawal symptoms].

  2012cites this paper
• Disturbance of consciousness and involuntary movements caused by pregabalin

  2012cites this paper
• Pregabalin in clinical psychiatry and addiction: pros and cons

  2012cites this paper
• Tolerability and use in co-administration of pregabalin in affective patients: a 6-month prospective naturalistic study

  2012cites this paper
• Effects of Pregabalin on Subjective Sleep Disturbance Symptoms during Withdrawal from Long-Term Benzodiazepine Use

  2011cites this paper
• Benzodiazepines revisited--will we ever learn?

  2011cites this paper